Company / Depreciation & Amortization
CASTLE BIOSCIENCES INC Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$40.8M
FY2025
5-year range
$3.4M / $40.8M
FY2021-FY2025
Trend
+154.9%
vs FY2024
Sector context
#86 of 147
Health Care
What the data says
At $41M, CASTLE BIOSCIENCES INC's depreciation & amortization ranks #62 of 147 in the Health Care sector. Depreciation & Amortization has increased for 6 consecutive years, from $287,000 in FY2018 to $41M in FY2025.
Based on SEC 10-K filings.
$41M in FY2025 with a 5-year CAGR of +143.9%.
Increased from $12M to $41M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +57.0%
- 5-Year CAGR
- +143.9%
- 10-Year CAGR
- -
Sector benchmark
#62 of 147 in Health CareTop 41% of 147This company $40.8M Sector average $338.5M
▼
-88.0% below sector average
Key checks
Key Insights
- CASTLE BIOSCIENCES INC's depreciation & amortization has grown for 5 consecutive years.
- 5-year CAGR of +143.9%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 154.9% year-over-year.
- Ranks #86 out of 147 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.8M | +154.9% |
| FY2024 | $16.0M | +29.7% |
| FY2023 | $12.3M | +16.9% |
| FY2022 | $10.5M | +209.5% |
| FY2021 | $3.4M | +621.8% |
| FY2020 | $472.0K | - |
| FY2019 | - | - |
| FY2018 | $287.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026